• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session

    8/19/22 12:23:10 PM ET
    $AFRM
    $AGLE
    $APDN
    $ARCE
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AFRM alert in real time by email

    Gainers

    • GigaCloud Technology Inc (NASDAQ:GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.
    • Volcon, Inc. (NASDAQ:VLCN) gained 51% to $2.7899 after the company announced it has received over $100 million of pre-production orders for the Stag
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) shares jumped 41.2% to $0.7131 after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) gained 41% to $59.84 after the company announced the U.S. FDA has approved Auvelity for the treatment of major depressive disorder in adults.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) shares rose 28.8% to $1.2875. Summit Therapeutics CEO Robert W Duggan acquired a total of 94,849,203 shares at an average price of $0.97.
    • TDH Holdings, Inc. (NASDAQ:PETZ) shares climbed 25.3% to $3.7350. TDH Holdings acquired 100% of the equity interests of Beijing Wenxin Company., Ltd.
    • Assure Holdings Corp. (NASDAQ:IONM) rose 23.3% to $1.47. Assure Hldgs recently posted Q2 loss of $0.37 per share.
    • Foot Locker, Inc. (NYSE:FL) gained 21.2% to $38.76 after the company reported Q2 results and announced a CEO transition. B of A Securities and Citigroup upgraded their ratings on the stock.
    • Taylor Devices, Inc. (NASDAQ:TAYD) rose 21.2% to $10.23 after reporting a sharp rise in Q4 earnings.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) gained 20.4% to $1.5530 after the company reported Q2 year over year sales growth of 273%.
    • Bill.com Holdings, Inc. (NYSE:BILL) shares climbed 17% to $174.76 after the company announced better-than-expected Q4 results and issued sales guidance above estimates.
    • Applied DNA Sciences, Inc. (NASDAQ:APDN) gained 16% to $4.1769. Applied DNA submitted PCR-based Monkeypox virus diagnostic test for approval to New York State Department of Health.
    • Endo International plc(NASDAQ:ENDP) rose 15.2% to $0.4675 after jumping 43% on Thursday. Endo International recently filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
    • SaverOne 2014 Ltd (NASDAQ:SVRE) gained 14.6% to $2.99.
    • Cybin Inc. (NYSE:CYBN) jumped 13.5% to $1.0207. Cybin recently announced the DEA has granted a Schedule I license to support the first-in-human Phase 1/2a clinical trial of CYB003 for the treatment of major depressive disorder.
    • LumiraDx Limited (NASDAQ:LMDX) rose 13.3% to $1.36. LumiraDx recently reported worse-than-expected Q2 adjusted EPS and sales results.
    • Secoo Holding Limited (NASDAQ:SECO) gained 10.7% to $0.2636 following announcement of equity investment led by private equity firm HCYK.
    • Magenta Therapeutics, Inc. (NASDAQ:MGTA) jumped 9.6% to $1.70. Magenta Therapeutics said it may offer and sell shares up to $50 million.
    • Party City Holdco Inc. (NYSE:PRTY) gained 9% to $2.15.
    • Avaya Holdings Corp. (NYSE:AVYA) rose 8.4% to $0.7059. Avaya recently received New York Stock Exchange notice regarding late form 10-Q filing.
    • Marpai, Inc. (NASDAQ:MRAI) rose 6.5% to $0.8516. Marpai Director Yaron Eitan recently acquired a total of 31,000 shares at an average price of $0.79.


    Losers

    • Capstone Green Energy Corporation (NASDAQ:CGRN) fell 40.9% to $2.33 after the company announced the pricing of a public offering of 2,934,498 shares valued at approximately $8 million.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) shares fell 40.5% to $11.03 after an amended 13D filing showed Ryan Cohen has a 0% stake in the company.
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 28.3% to $1.7850 after the company announced the pricing of a public offering of 17,500,000 shares valued at approximately $35 million.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) fell 25.4% to $1.6141. Shares of Bright Minds Biosciences jumped 136% on Thursday amid an increase in retail investor interest.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 25.3% to $0.2114. Clarus Therapeutics posted a Q2 loss of $0.24 per share.
    • StoneCo Ltd. (NASDAQ:STNE) fell 25% to $8.75 after the company reported Q2 results and said Marcelo Baldin, Chief Financial Officer, is departing from the company.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 24.5% to $1.0950.
    • Eqonex Limited (NASDAQ:EQOS) dropped 22.4% to $0.50.
    • Lizhi Inc. (NASDAQ:LIZI) shares fell 17.5% to $1.45 after reporting Q2 results.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) dropped 17.2% to $18.10 after the company reported worse-than-expected Q2 EPS results and issued Q3 sales guidance below estimates.
    • Second Sight Medical Products, Inc. (NASDAQ:EYES) fell 16.8% to $4.59.
    • Reunion Neuroscience Inc. (NASDAQ:REUN) dropped 16.2% to $3.4512.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 16% to $1.6966. Neptune Wellness shares jumped around 50% on Thursday after the company announced sales have outperformed Walmart's expectations.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) declined 16% to $5.31. Shares of crypto-related stocks traded lower amid a drop in Bitcoin and Ethereum prices.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) dipped 15.8% to $5.87.
    • Wayfair Inc. (NYSE:W) dropped 14.7% to $60.88 after the company announced it will cut its workforce by approximately 870 employees, representing approximately 5% of its global workforce and approximately 10% of its corporate team.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) shares fell 14.5% to $0.77 after dropping 18% on Thursday.
    • Arco Platform Limited (NASDAQ:ARCE) dropped 14% to settle at $13.53 following Q2 results.
    • 23andMe Holding Co. (NASDAQ:ME) fell 13.5% to $3.6150. 23andMe announced that the company’s CFO Steven Schoch will resign, effective September 1.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) dropped 13.1% to $1.1650.
    • Power REIT (NYSE:PW) fell 13.1% to $17.80. Power REIT recently posted Q2 FFO of $0.41.
    • Marathon Digital Holdings, Inc (NASDAQ:MARA) fell 12.4% to $13.64 amid a decline in Bitcoin and Ethereum prices.. Marathon Digital recently posted a Q2 loss of $1.75 per share.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) dropped 12% to $31.46.
    • Hut 8 Mining Corp. (NASDAQ:HUT) fell 11.9% to $2.37 after declining 10% on Thursday. The company launched at-the-market equity program of up to $200 million.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) declined 10.8% to $6.39.
    • Biophytis S.A. (NASDAQ:BPTS) dipped 10.7% to $1.00.
    • SmartRent, Inc. (NYSE:SMRT) fell 10.6% to $3.3804.
    • Coinbase Global, Inc. (NASDAQ:COIN) dipped 9.9% to $75.24. Shares of crypto-related stocks traded lower amid a drop in Bitcoin and Ethereum prices.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 9.9% to $0.7641. Plus Therapeutics shares gained 54% on Thursday after the company announced it was awarded $17.6 million Product Development Research grant by the Cancer Prevention and Research Institute of Texas to fund radiotherapeutic, Rhenium-186 NanoLiposome
    • MicroStrategy Incorporated (NASDAQ:MSTR) fell 9.7% to $292.57 amid a decline in Bitcoin and Ethereum prices.
    • Bumble Inc. (NASDAQ:BMBL) dipped 9.3% to $28.48.
    • Riot Blockchain, Inc. (NASDAQ:RIOT) fell 9.2% to $7.51 amid a decline in Bitcoin and Ethereum prices.
    • VistaGen Therapeutics, Inc. (NASDAQ:VTGN) fell 7% to $1.6141. VistaGen Therapeutics reported in Form4 filing that CEO Shawn K. Singh bought 600,000 shares at average price of $0.17 per share.
    • GameStop Corp. (NYSE:GME) fell 6.4% to $35.50 after dropping more than 6% on Thursday.
    Get the next $AFRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFRM
    $AGLE
    $APDN
    $ARCE

    CompanyDatePrice TargetRatingAnalyst
    Affirm Holdings Inc.
    $AFRM
    4/22/2026$75.00Outperform
    BMO Capital Markets
    Bright Minds Biosciences Inc.
    $DRUG
    4/13/2026$145.00Buy
    Jefferies
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    Coinbase Global Inc.
    $COIN
    4/8/2026$140.00Equal Weight → Underweight
    Barclays
    Hut 8 Corp.
    $HUT
    3/23/2026$136.00Buy
    Arete
    Summit Therapeutics Inc.
    $SMMT
    3/16/2026$15.00Buy → Hold
    Jefferies
    Bumble Inc.
    $BMBL
    3/12/2026Underweight → Neutral
    Analyst
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    More analyst ratings

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    StoneCo Files Its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

    George Town, Grand Cayman--(Newsfile Corp. - April 23, 2026) - StoneCo Ltd. (NASDAQ:STNE) ("Stone" or "the Company") hereby informs its shareholders and the market that has filed today, April 23, its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC").The report is available on the SEC's website, at www.sec.gov, and on StoneCo's Investor Relations website, at https://investors.stone.co. About StoneCoStone Co. is a leading provider of financial technology solutions that empower merchants to conduct commerce seamlessly across multiple channels and help them grow their businesses with our payments, banking, and cre

    4/23/26 6:02:00 PM ET
    $STNE
    EDP Services
    Technology

    Grove to Report First Quarter 2026 Financial Results on May 7, 2026

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, Certified B Corporation, and Public Benefit Corporation today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call will be available u

    4/23/26 4:05:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    The Container Store Launches Nationwide Overhaul Across 98 Stores

    30% category and SKU liquidation required to make way for Bed Bath & Beyond merger The Container Store today announced the launch of a chainwide "Store Changing" event beginning Friday, April 24, as 98 stores nationwide begin resetting selling floors to prepare for the phased integration of Bed Bath & Beyond products. As part of the reset, the Company will liquidate approximately 30% of select categories and SKUs beginning Friday to streamline assortments, improve space productivity and create room for new products expected to arrive in phases later this year. The initiative is a planned step in reimagining the combined in-store experience. "This is a reset with purpose," said Jen Pap

    4/23/26 8:00:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Operating Officer Bansi Pankaj

    4 - SmartRent, Inc. (0001837014) (Issuer)

    4/24/26 7:02:14 PM ET
    $SMRT
    EDP Services
    Technology

    SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:45 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Executive Officer Tabuteau Herriot

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:29 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Leadership Updates

    Live Leadership Updates

    View All

    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that it has granted inducement awards to Eric J Daniels, M.D., its new Chief Development Officer who joined the Company on April 20, 2026. The awards were granted on April 20, 2026 under the Company's 2015 New Employee Incentive Plan, as amended, which provides for the granting of equity awards to new employees as an inducement to join the Company. The inducement awards consist of options to purchase 20,000 shares of the Company common

    4/22/26 4:30:00 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

    HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the appointment of Randy H. Goodman, Ph.D., M.H.A., as Vice President, Value Strategy & Health Economics and Outcomes Research (HEOR), effective April 13th, 2026. Dr. Goodman is a highly experienced health economics and market access leader with more than 20 years of experience spanning global pricing and reimbursement strategy, real-world evidence generation, and value-based healthcare modeling across the biotechnology, pharmaceutic

    4/15/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

    HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announced the appointment of Eric J. Daniels, M.D., MBA, as Chief Development Officer, effective April 20, 2026. Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most recently served as Chief Development Officer at Kiora Pharmaceuticals , where he oversaw the company's full development portfolio

    4/9/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $AFRM
    $AGLE
    $APDN
    $ARCE
    SEC Filings

    View All

    SEC Form DEFA14A filed by Axsome Therapeutics Inc.

    DEFA14A - Axsome Therapeutics, Inc. (0001579428) (Filer)

    4/24/26 5:02:38 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Axsome Therapeutics Inc.

    DEF 14A - Axsome Therapeutics, Inc. (0001579428) (Filer)

    4/24/26 5:01:36 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Edible Garden AG Incorporated filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Edible Garden AG Inc (0001809750) (Filer)

    4/24/26 4:30:25 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $AFRM
    $AGLE
    $APDN
    $ARCE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AUVELITY issued to AXSOME THERAPEUTICS, INC.

    Submission status for AXSOME THERAPEUTICS, INC.'s drug AUVELITY (ORIG-1) with active ingredient DEXTROMETHORPHAN HYDROBROMIDE AND BUPROPION HYDROCHLORIDE has changed to 'Approval' on 08/18/2022. Application Category: NDA, Application Number: 215430, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    8/19/22 12:36:14 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Bohjalian Thomas N bought $260,490 worth of shares (150,000 units at $1.74), increasing direct ownership by 43% to 500,000 units (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    3/12/26 6:25:23 PM ET
    $SMRT
    EDP Services
    Technology

    Large owner Posner Henry Iii bought $162,929 worth of 7.75% Series A Cum. Red. Perpetual Preferred Stock (24,633 units at $6.61), increasing direct ownership by 263% to 34,000 units (SEC Form 4)

    4 - Power REIT (0001532619) (Issuer)

    2/10/26 2:53:54 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Affirm with a new price target

    BMO Capital Markets initiated coverage of Affirm with a rating of Outperform and set a new price target of $75.00

    4/22/26 7:55:46 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Jefferies initiated coverage on Bright Minds Biosciences with a new price target

    Jefferies initiated coverage of Bright Minds Biosciences with a rating of Buy and set a new price target of $145.00

    4/13/26 8:51:07 AM ET
    $DRUG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stifel initiated coverage on Summit Therapeutics with a new price target

    Stifel initiated coverage of Summit Therapeutics with a rating of Buy and set a new price target of $45.00

    4/8/26 8:38:26 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Financials

    Live finance-specific insights

    View All

    Grove to Report First Quarter 2026 Financial Results on May 7, 2026

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, Certified B Corporation, and Public Benefit Corporation today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call will be available u

    4/23/26 4:05:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    BILL to Report Fiscal Third Quarter 2026 Financial Results

    BILL (NYSE:BILL), the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, announced today it will report financial results for its fiscal third quarter ended March 31, 2026 on Thursday, May 7, 2026 after the close of market. Management will conduct a conference call to discuss these results at 1:30 p.m. PT. The news release with financial results and a live webcast of the call will be accessible at https://investor.bill.com. Webcast replays can be accessed from BILL's Investor Relations website for approximately one year after the call. About BILL BILL (NYSE:BILL) is the intelligent finance platform trusted by nearly half a milli

    4/22/26 4:05:00 PM ET
    $BILL
    EDP Services
    Technology

    $AFRM
    $AGLE
    $APDN
    $ARCE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Power REIT (MD)

    SC 13D/A - Power REIT (0001532619) (Subject)

    12/10/24 5:55:44 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Accelerate Diagnostics Inc.

    SC 13D/A - Accelerate Diagnostics, Inc (0000727207) (Subject)

    12/5/24 5:13:13 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials